当前位置:首页 - 行情中心 - 亿帆医药(002019) - 财务分析 - 现金流量表

亿帆医药

(002019)

  

流通市值:108.21亿  总市值:156.43亿
流通股本:8.41亿   总股本:12.16亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金1,322,551,834.764,883,376,838.973,840,344,662.082,381,147,493.06
收到的税费返还20,511,692.6786,321,647.8379,166,446.3127,652,095.14
收到其他与经营活动有关的现金68,552,508.69357,428,098.84194,208,996.45120,608,932.99
经营活动现金流入的平衡项目0000
经营活动现金流入小计1,411,616,036.125,327,126,585.644,113,720,104.842,529,408,521.19
购买商品、接受劳务支付的现金706,995,791.042,042,147,533.691,815,670,397.881,403,867,322.34
支付给职工以及为职工支付的现金238,119,151.85795,480,074.94614,398,547.97417,238,437.57
支付的各项税费159,921,795.37408,011,619.98300,267,912.12245,680,047.22
支付其他与经营活动有关的现金124,243,880.571,440,757,164.381,029,973,622.8318,848,495.11
经营活动现金流出的平衡项目0000
经营活动现金流出小计1,229,280,618.834,686,396,392.993,760,310,480.772,385,634,302.24
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额182,335,417.29640,730,192.65353,409,624.07143,774,218.95
二、投资活动产生的现金流量:
收回投资收到的现金-791,461,040.25475,879,324160,865,423.2
取得投资收益收到的现金-2,668,983.311,035,831.99755,408.96
处置固定资产、无形资产和其他长期资产收回的现金净额3,820,416321,264192,313.6287,580
处置子公司及其他营业单位收到的现金净额-5,287,258.815,287,258.815,287,258.81
投资活动现金流入的平衡项目0000
投资活动现金流入小计3,820,416799,738,546.37482,394,728.4167,195,670.97
购建固定资产、无形资产和其他长期资产支付的现金111,178,114.14628,156,384.41385,213,076.39256,508,015.29
投资支付的现金-716,461,040.25465,879,324106,153,897.6
投资活动现金流出的平衡项目0000
投资活动现金流出小计111,178,114.141,344,617,424.66851,092,400.39362,661,912.89
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-107,357,698.14-544,878,878.29-368,697,671.99-195,466,241.92
三、筹资活动产生的现金流量:
吸收投资收到的现金-1,000,0001,000,0001,000,000
其中:子公司吸收少数股东投资收到的现金-1,000,0001,000,0001,000,000
取得借款收到的现金517,691,345.272,001,328,182.481,696,424,044.34877,434,173.6
收到其他与筹资活动有关的现金295,840.534,292,003.9234,011,802.5733,734,949.41
筹资活动现金流入平衡项目0000
筹资活动现金流入小计517,987,185.772,036,620,186.41,731,435,846.91912,169,123.01
偿还债务支付的现金585,688,486.041,692,852,819.41,173,759,041.66648,743,878.01
分配股利、利润或偿付利息支付的现金13,758,260.06207,734,220.62192,954,021.3345,178,999.25
其中:子公司支付给少数股东的股利、利润-12,921,125.6412,919,696.3712,525,159.95
支付其他与筹资活动有关的现金4,914,870.3523,301,426.0520,080,136.5210,453,097.17
筹资活动现金流出平衡项目0000
筹资活动现金流出小计604,361,616.451,923,888,466.071,386,793,199.51704,375,974.43
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-86,374,430.68112,731,720.33344,642,647.4207,793,148.58
四、汇率变动对现金及现金等价物的影响2,144,060.32-3,691,057.98-2,338,325.28-897,603.02
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-9,252,651.21204,891,976.71327,016,274.2155,203,522.59
加:期初现金及现金等价物余额777,637,857.9572,745,881.19572,745,881.19572,745,881.19
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额768,385,206.69777,637,857.9899,762,155.39727,949,403.78
补充资料:
净利润-323,621,712.62-212,445,979.23
资产减值准备-164,891,357.65-61,650,093.8
固定资产和投资性房地产折旧-122,293,825.84-65,268,493.35
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-122,293,825.84-65,268,493.35
无形资产摊销-198,531,474.31-95,467,976.04
长期待摊费用摊销-9,931,445.18-5,477,520.37
处置固定资产、无形资产和其他长期资产的损失--30,145,653.64--2,198,867.23
固定资产报废损失-676,450.07-52,975.3
财务费用-69,100,599.7-33,443,730.44
投资损失-14,164,575.31-1,288,863.23
递延所得税-4,597,712.37-31,242,128.94
其中:递延所得税资产减少-12,604,887.77-33,804,464.56
递延所得税负债增加--8,007,175.4--2,562,335.62
存货的减少--147,751,762.24--148,132,939.71
经营性应收项目的减少--363,718,239--444,391,536.22
经营性应付项目的增加-239,989,502.62-226,162,146.41
其他-19,705,816.39--1,664,435.95
现金的期末余额-777,637,857.9-727,949,403.78
减:现金的期初余额-572,745,881.19-572,745,881.19
公告日期2025-04-302025-04-282024-10-312024-08-15
审计意见(境内)标准无保留意见
TOP↑